American College of Medical Genetics
American College of Medical Genetics Lauds Federal Court Ruling of
Published in Medical Patent Law Weekly, April 14th, 2010
The outcome of this case is likely to have far-reaching positive implications for physicians, researchers and patients.
"The invalidation of gene patents will allow patients to get second opinions on test results, encourage quality improvement of current testing, allow researchers to develop new and better methods of testing and decrease costs of laboratory testing. This is a huge, huge victory for better patient care," said Michael S. Watson,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Alnylam Pharmaceuticals, Inc.
Alnylam Announces Additional Grant of Tuschl II Patent in Japan - Alternatives to Laboratory Animals
Scientists at MatTek describe research in alternatives to laboratory animals - American Science and Engineering, Inc.
American Science and Engineering, Inc. Receives $3.0 Million Order from the Middle East for Multiple ZBVs - Antifungals
Data from Mississippi State University advance knowledge in antifungals - Antimicrobials
Investigators at University of Louisville zero in on antimicrobials - Antiretrovirals
Study data from N. Khatib et al provide new insights into antiretrovirals - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
